Looks like reaccumulation on NVAXI was wrong about the potential timing. But this still looks promising to me. This looks like a solid reaccumulation for NVAX. Should go up with the Russel 2000 if that ever has a breakout this cycle. Just my best guess.Longby pridefulSeafow702052215
NVAX Potential Breakout!Potential Breakout in the next week for NVAX. Would not be surprised to see a move to around $10.60 in the next few days. If it can break the bigger wedge, a potential big upside to around $14-$15 range. Besides this short term idea, the stock has even greater upside from a TA point of view if youLongby Frisoburg335
$NVAX - GAP FILL & BREAK OF TRANEDLINE NASDAQ:NVAX gaining momentum again along with other pharma's. Its interestingly filling the gap anf has i high possibility of retesting the high of the channel. I have a starter position and will be adding if it decides to test the trend line. A daily close below the trendline is my stop. Playing eLongby BUMISHO443
Shot At Vaccinating Gains!Novavax (NVAX) is demonstrating strong bullish momentum, with a gap forming around the $8.75 level. A breakout above the $14.60 monthly resistance would confirm continued strength, positioning the stock to target $23.71. This trade offers an excellent risk-to-reward ratio, with downside risk managedLongby The_Trading_Mechanic9
NVAX: confirmed bottom and go up from here!NVAX: confirmed bottom and go up from here! -Quasimodo pattern. -Bull flag pattern. -Less supply volume at the bottom. -Waiting for demand volume confirms and go up from here. . Wait n see!Longby usstockswallstreetdream9
Bull NVAX - novavax 150 dollar targetI am looking for a 150 dollar target on Novavax but not invested in this since my bank (Handelsbanken) don't supply this. Longby dayg632210
Novavax Set to Soar: A Bullish Breakout in Sight?Unveiling the Potential of NVAX Novavax (NVAX), a notable biopharmaceutical stock, has witnessed a dramatic journey, plunging from its February 2021 high of approximately $330 to a critical low of $3.53 in February 2024. While this decline may appear daunting, our technical analysis suggests that iby VitalDirection776
$NVAX #nvax $24 target by 12/9/2024Novavax, NASDAQ:NVAX phase 3 trial begins on 12/9/2024. ctv.veeva.com A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine Shortby trader065106
$NVAX $24 Dec 9, 2024NASDAQ:NVAX Novavax stock, $24 on 12/9/24. ctv.veeva.com Phase 3 trial begins on Monday, Dec. 9, 2024. Squeezing. Shortby trader065101